journal article·2026-06Open access

A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing

Maria Alexaki, Attilio Marino, Marie Celine Lefevre, Claudio Canale, Davide Odino, João F. Mano, Mariana B. Oliveira, Gianni Ciofani

Abstract

The development of physiologically relevant in vitro models of the blood-brain barrier (BBB) is critical for reliable assessment of drug permeability and neurotherapeutic transport. Current platforms often fail to reproduce the three-dimensional geometry and mechanical compliance of cerebral microvessels, limiting their translational relevance. Here, we report the fabrication of soft, flexible and self-supporting tubular membranes via polyelectrolyte complexation of alginate and ε-poly-L-lysine, yielding cylindrical constructs that closely mimic the architecture and flexibility of small brain vessels. The resulting biomaterials support robust endothelial cell adhesion and the formation of a functional barrier, exhibiting controlled permeability consistent with selective molecular transport. Importantly, the compliant tubular constructs enable the application of external mechanical compression, allowing controlled modulation of vessel deformation and barrier integrity in a manner relevant to pathological conditions such as tumor-induced vascular compression. By integrating physiologically relevant cylindrical geometry with a mechanically compliant and deformable microenvironment, this platform provides a tunable and reproducible basis for endothelial barrier formation and mechanical perturbation, enabling the development of a more biomimetic in vitro BBB model.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Barrier Structure and Function Studies · Nanoparticle-Based Drug Delivery · Cerebrospinal fluid and hydrocephalus

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. The blood–brain barrier: a help and a hindrance10.1093/brain/awaf068 ↗
2. The blood-brain barrier10.1016/j.cub.2025.06.061 ↗
3. The blood-brain barrier10.1101/cshperspect.a020412 ↗
4. Blood-brain barrier: from physiology to disease and back10.1152/physrev.00050.2017 ↗
5. Recent advances in blood-brain barrier-on-a-chip models10.1016/j.actbio.2025.03.041 ↗
6. 3D in vitro blood–brain barrier models: recent advances and their role in brain disease research and therapy
7. Microfluidic systems to mimic the blood–brain barrier: from market to engineering challenges and perspectives10.1021/acsbiomaterials.4c02221 ↗
8. Organ-on-a-Chip approach for accelerating blood–brain barrier nanoshuttle discovery10.1021/acsnano.4c00994 ↗
9. Assessing haemorrhage-critical values of cerebral blood flow by modelling biomechanical stresses on capillaries in the immature brain10.1038/s41598-020-71087-7 ↗
10. In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice10.1152/ajpheart.00417.2011 ↗
11. Mechanobiology of the blood-brain barrier during development, disease and ageing10.1038/s41467-025-61888-7 ↗
12. Tension at the gate: sensing mechanical forces at the blood–brain barrier in health and disease10.1186/s12974-024-03321-2 ↗
13. Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology10.1007/s00401-004-0822-6 ↗
14. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy10.1159/000334916 ↗
15. Mechanical forces in tumor angiogenesis10.1007/978-3-319-95294-9_6 ↗
16. All-aqueous freeform fabrication of perfusable self-standing soft compartments10.1002/adma.202200352 ↗
17. One-step all-aqueous interfacial assembly of robust membranes for long-term encapsulation and culture of adherent stem/stromal cells10.1002/adhm.202100266 ↗
18. Exploring the potential of all-aqueous immiscible systems for preparing complex biomaterials and cellular constructs10.1039/D4MH00431K ↗
19. Understanding fabrication variability in core-shell soft biomaterials using stochastic artificial intelligence10.1002/advs.202522389 ↗
20. Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium10.1038/s41551-018-0334-7 ↗
21. Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies10.1073/pnas.1818322116 ↗
22. Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside10.1016/j.trecan.2018.02.005 ↗
23. Cells of the blood-brain barrier: an overview of the neurovascular unit in health and disease10.1007/978-1-0716-2289-6_1 ↗
24. Spontaneous formation of solid shell polymeric multicompartments at all-aqueous interfaces10.1002/advs.202402592 ↗
25. Benchmarking in vitro tissue-engineered blood–brain barrier models10.1186/s12987-018-0117-2 ↗
26. Validation and characterization of a novel blood–brain barrier platform for investigating traumatic brain injury10.1038/s41598-023-43214-7 ↗
27. Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms10.1038/s41467-019-13896-7 ↗
28. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening10.1002/bit.26045 ↗
29. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line10.1186/s12987-023-00501-9 ↗
30. An improved in vitro blood-brain barrier model for the evaluation of drug permeability using transwell with shear stress10.3390/pharmaceutics16010048 ↗
31. A face-to-face comparison of the BBB cell models hCMEC/D3 and hBMEC for their applicability to adenoviral expression of transporters10.1111/jnc.16125 ↗
32. Real-time monitoring of a 3D blood-brain barrier model maturation and integrity with a sensorized microfluidic device10.1039/D4LC00633J ↗
33. A review of approaches to potentiate the activity of temozolomide against glioblastoma to overcome resistance10.3390/ijms25063217 ↗
34. Delivery of doxorubicin across the blood–brain barrier by ondansetron pretreatment: a study in vitro and in vivo10.1016/j.canlet.2014.07.018 ↗
35. Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors10.1007/s00280-022-04424-4 ↗
36. The effects of doxorubicin on blood-brain barrier integrity in hCMEC/D310.1016/j.neuro.2025.103355 ↗
37. A microfluidic blood brain barrier model to study the influence of glioblastoma tumor cells on BBB function10.1002/smll.202411361 ↗